S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Kuehn Law Launches Investigation Into TG Therapeutics Leadership

Shareholders of TG Therapeutics, Inc. are under scrutiny as New York-based firm Kuehn Law, PLLC investigates potential fiduciary breaches by company officers and directors. The inquiry centers on allegations of self-dealing, with the firm inviting long-term investors to participate in a potential legal challenge regarding corporate governance and damages.

Kuehn Law Launches Investigation Into TG Therapeutics Leadership
Photo: Bio & News

The investigation targets whether leadership at the NASDAQ-listed firm prioritized personal interests over their obligations to shareholders. Kuehn Law is currently soliciting contact from TGTX stockholders to assess the scope of the alleged misconduct and determine if formal litigation is warranted to enforce investor rights.

Those interested in the case are encouraged to reach out to Sophia Anne Silayan for a consultation. The firm operates on a contingency basis, covering all litigation costs without charging investor clients for their participation. Because legal avenues for shareholder recovery are often time-sensitive, the firm is urging stakeholders to act immediately to ensure their interests are represented in any subsequent proceedings.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!